Progress toward re‐engineering non‐ribosomal peptide synthetase proteins: a potential new source of pharmacological agents

Many important pharmaceutical agents, including vancomycin, bleomycin, cyclosporin, and several antibiotics, are produced by non‐ribosomal peptide synthetase (NRPS) enzymes in microorganisms. The NRPS pathway produces an extensive library of products using multienzyme complexes acting in an assembly‐line fashion. Engineering an NRPS system to produce an even greater variety of products, some of which may also have beneficial therapeutic value, would be an enormous advantage. Several approaches have been successful in generating novel NRPS products: mutational biosynthesis during which nonnatural substrates are fed to an organism; domain and module swapping between different species to generate hybrid enzymes; and rational site‐directed mutagenesis, based either on phylogeny or computational prediction, intended to switch substrate specificity and produce altered products. This review will highlight the progress in these areas and describe research in the future that will extend the capacity for re‐engineering NRPS systems. Drug Dev. Res. 66:9–18, 2006. © 2006 Wiley‐Liss, Inc.

[1]  M. Marahiel,et al.  Structural basis for the cyclization of the lipopeptide antibiotic surfactin by the thioesterase domain SrfTE. , 2002, Structure.

[2]  C. Walsh,et al.  Harnessing the biosynthetic code: combinations, permutations, and mutations. , 1998, Science.

[4]  M. Marahiel,et al.  Solution structure of PCP, a prototype for the peptidyl carrier domains of modular peptide synthetases. , 2000, Structure.

[5]  M. Marahiel,et al.  Nonribosomal peptides: from genes to products. , 2003, Natural product reports.

[6]  T. Stachelhaus,et al.  Rational design of peptide antibiotics by targeted replacement of bacterial and fungal domains. , 1995, Science.

[7]  P. Brick,et al.  Structural basis for the activation of phenylalanine in the non‐ribosomal biosynthesis of gramicidin S , 1997, The EMBO journal.

[8]  Christopher T. Walsh,et al.  The structure of VibH represents nonribosomal peptide synthetase condensation, cyclization and epimerization domains , 2002, Nature Structural Biology.

[9]  D K Robinson,et al.  Metabolic engineering and directed evolution for the production of pharmaceuticals. , 2000, Current opinion in biotechnology.

[10]  K. Nicolaou,et al.  Total Synthesis of Vancomycin Aglycon-Part 3: Final Stages. , 1998, Angewandte Chemie.

[11]  M. Marahiel,et al.  Construction of hybrid peptide synthetases by module and domain fusions. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[12]  G. Challis,et al.  Predictive, structure-based model of amino acid recognition by nonribosomal peptide synthetase adenylation domains. , 2000, Chemistry & biology.

[13]  W. Saenger,et al.  Modification of biologically active peptides: production of a novel lipohexapeptide after engineering of Bacillus subtilis surfactin synthetase. , 2002, Protein engineering.

[14]  Mohamed A. Marahiel,et al.  Modular Peptide Synthetases Involved in Nonribosomal Peptide Synthesis. , 1997, Chemical reviews.

[15]  Jason Micklefield,et al.  Structure, biosynthetic origin, and engineered biosynthesis of calcium-dependent antibiotics from Streptomyces coelicolor. , 2002, Chemistry & biology.

[16]  M. Marahiel,et al.  Portability of epimerization domain and role of peptidyl carrier protein on epimerization activity in nonribosomal peptide synthetases. , 2001, Biochemistry.

[17]  M. Marahiel,et al.  Crystal structure of DhbE, an archetype for aryl acid activating domains of modular nonribosomal peptide synthetases , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[18]  T. Stachelhaus,et al.  Aminoacyl-CoAs as probes of condensation domain selectivity in nonribosomal peptide synthesis. , 1999, Science.

[19]  Kira J Weissman,et al.  The structure of docking domains in modular polyketide synthases. , 2003, Chemistry & biology.

[20]  R. Süssmuth,et al.  Mutational biosynthesis—a tool for the generation of structural diversity in the biosynthesis of antibiotics , 2005, Applied Microbiology and Biotechnology.

[21]  T. Stachelhaus,et al.  Targeted alteration of the substrate specificity of peptide synthetases by rational module swapping , 1998, Molecular and General Genetics MGG.

[22]  C. Walsh,et al.  Tailoring enzymes that modify nonribosomal peptides during and after chain elongation on NRPS assembly lines. , 2001, Current opinion in chemical biology.

[23]  M. Marahiel,et al.  Decreasing the ring size of a cyclic nonribosomal peptide antibiotic by in-frame module deletion in the biosynthetic genes. , 2002, Journal of the American Chemical Society.

[24]  M. Marahiel,et al.  Design and application of multimodular peptide synthetases. , 1999, Current opinion in biotechnology.

[25]  M. Marahiel,et al.  Dipeptide formation on engineered hybrid peptide synthetases. , 2000, Chemistry & biology.

[26]  D. Ackerley,et al.  Substrate Specificity of the Nonribosomal Peptide Synthetase PvdD from Pseudomonas aeruginosa , 2003, Journal of bacteriology.

[27]  Bruce Randall Donald,et al.  A Novel Ensemble-Based Scoring and Search Algorithm for Protein Redesign and Its Application to Modify the Substrate Specificity of the Gramicidin Synthetase A Phenylalanine Adenylation Enzyme , 2005, J. Comput. Biol..

[28]  D. Boger.  Vancomycin, teicoplanin, and ramoplanin: Synthetic and mechanistic studies † , 2001, Medicinal research reviews.

[29]  U. Bornscheuer,et al.  Directed evolution of an esterase for the stereoselective resolution of a key intermediate in the synthesis of epothilones. , 1998, Biotechnology and bioengineering.

[30]  T. Stachelhaus,et al.  Exploitation of the selectivity-conferring code of nonribosomal peptide synthetases for the rational design of novel peptide antibiotics. , 2002, Biochemistry.

[31]  G. Challis,et al.  Substrate recognition by nonribosomal peptide synthetase multi-enzymes. , 2004, Microbiology.

[32]  J. Barrow,et al.  Total Syntheses of Vancomycin and Eremomycin Aglycons. , 1998, Angewandte Chemie.

[33]  H von Döhren,et al.  The nonribosomal code. , 1999, Chemistry & biology.

[34]  D. Boger,et al.  Total Synthesis of the Vancomycin Aglycon , 1999 .

[35]  M. Marahiel,et al.  Systematic and quantitative analysis of protein-protein recognition between nonribosomal peptide synthetases investigated in the tyrocidine biosynthetic template. , 2003, Biochemistry.

[36]  Christopher T Walsh,et al.  Polyketide and Nonribosomal Peptide Antibiotics: Modularity and Versatility , 2004, Science.

[37]  T. Stachelhaus,et al.  The specificity-conferring code of adenylation domains in nonribosomal peptide synthetases. , 1999, Chemistry & biology.

[38]  G. Jung,et al.  Fluorobalhimycin--a new chapter in glycopeptide antibiotic research. , 2002, Angewandte Chemie.